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Purpose: Adenosine acts as a potent anti-inflammatory autacoid; extracellular adenosine formation is generally thought to result from the sequential dephosphorylation of extracellular ATP to AMP by action of ectonuclease triphoshate diphosphohydrolase (CD39) followed by degradation to adenosine by ecto-5'-nucleotidase (CD73). The diverse cellular actions of adenosine are mediated by four specific membrane receptors (A1R, A2aR, A2bR and A3R). In animal models an up-regulation of ARs can be observed in cardiac tissue of failing heart (HF). Recently ARs mRNA expression has been assessed in human whole blood providing a useful tool to evaluate the expression of ARs in diseases characterized by a marked inflammatory component. The aim of this study was to evaluate the possible changes of transcriptomic profiling of A1R, A2aR, A2bR and A3R in human leukocytes of patients (pts) with valvular HF (Vlv) as compared to healthy subjects (C). Methods: Total RNA was extracted from leukocytes of C (n=7) and of Vlv pts (n= 6, NYHA III-IV) with PAXgene Blood RNA Kit (Qiagen, Milan, Italy). Real time PCR was performed and optimized for each ARs primer. CD39 and CD73 mRNA expression was also evaluated both in C and in Vlv pts. The experimental results were normalized with the three most stably expressed genes (SRP14, EEF1A, RPL13A). Results: In human whole blood of Vlv pts significantly higher levels of mRNA expression, for each receptors analyzed with respect to C were observed (A1R: C=1.97±0.72, Vlv pts=10.9±3.27, p=0.0098; A2aR: C=0.45±0.15, Vlv pts=3.19±0.94, p=0.0057; A2bR: C=0.43±0.16, Vlv pts=5.00±2.98, p=0.05; A3R: C=1.39±0.26, Vlv pts=2.9±0.71, p=0.04). Also CD39 and CD73 resulted upregulated in human leukocytes of Vlv pts with respect to C. Significant correlations (p<0.05) were observed between all ARs themself as well as with CD39 and CD73. Conclusions: The present study highlights, for the first time, an increase of ARs mRNA expression in the peripheral circulating cells of Vlv pts. The increase of CD39 and CD73 trascript levels is suggestive of a protective CD39-CD73-dependent adenosine production in advanced HF pts. These findings suggest that components of adenosine metabolism and signalling are altered to promote adenosine production and signalling in HF patients. Thus HF may benefit from adenosine-based drugs therapy after confirmation by clinical trials. Recent safety data emphasized the close link between chronic therapeutic use of serotonergic 5-HT2B receptors agonists and cardiac valve degeneration but the pharmacological mechanisms have not been clearly understood. Histopathological lesions show cell proliferation with extracellular matrix deposition that can drive to valvular leaflets stenosis, severe cardiac insufficiency and surgical valve replacement. In this work, we evaluated the effects of chronic administration of nordexfenfluramine (NDF) a highly selective 5-HT2B receptors agonist, on mice mitral valve leaflets. Adult male 129sv mice (aged 12 weeks) were randomly assigned in 10 different groups and underwent a subcutaneous micro-osmotic pump implantation delivering either NDF (1mg/kg/day) or vehicle (sterile water) for 4 weeks. Four groups were designed with wild-type mice: vehicle; NDF; NDF + ritanserine (2mg/kg/day); NDF + SB 206553 (1mg/kg/day) and two groups of each type of these knockout mice: 5-HT2A-/-; 5-HT2B-/-; 5-HT2A/2B-/-receiving either NDF or vehicle. Mice were monitored by regular body weight, food and water intake, blood pressure measurement and echocardiography. At the end of the experiment, urinary 5-HIAA was also monitored to appreciate serotonin synthesis. Hearts were harvested for histological analysis to quantify mitral valve leaflets thickness and cellularity. The comparison between wild-type vehicle treated and NDF mice didn't reveal any significant differences in terms of food or water intake, body weight, echocardiography parameters, beside of a slight blood pressure increase from 115±5 mmHg vs 124±6 mmHg for NDF treated mice. We also pointed out a significant increase of urinary amounts of 5-HIAA (52.65±7.38 mcg/L vs 74.18±4.53 mcg/L. Histological analysis of the heart revealed significant increased mitral valve leaflets thickness (35±6 micrometer vs 60±6 micrometer) and cellularity in NDF group (+20% vs control). These histological lesions are prevented in part by a pharmacological co-treatment with ritanserine and SB 206553 but not in NDF transgenic 5-HT2A-/-treated mice. However NDF induced mitral lesions were fully prevented in 5-HT2B -/-and 5-HT2A/2B -/-mice.
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In conclusion, we demonstrate the crucial role of 5-HT2B receptors in NDF induced valvulopathy. Experiments are currently evaluating cellular and molecular mechanisms. Purpose: Aortic valve stenosis (AVS) is an inflammatory atherosclerosis-like process characterized by valve interstitial cell (VIC) proliferation and commitment to fibrocalcification. No effective medical treatment is currently able to alter AVS clinical course. Tissue factor (TF) and thrombin expressions were previously shown to be significantly associated with fibrocalcification in human stenosed aortic valves. We investigated differential TF expression in normal and pathological valves and VIC and further described its signalling pathways in profibrosis commitment of normal VIC. Methods: We collected 50 fibrocalcific and 6 normal human aortic valves from which tissue lysates and VIC were isolated. VIC phenotype was analysed by flow cytometry. Normal VIC were stimulated or not with IL-1beta (major inflammatory cytokine involved in AVS at 1 ng/mL). In valve lysates and in VIC, TF and PAR
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